JP2944759B2 - 抗菌性組成物 - Google Patents

抗菌性組成物

Info

Publication number
JP2944759B2
JP2944759B2 JP52719495A JP52719495A JP2944759B2 JP 2944759 B2 JP2944759 B2 JP 2944759B2 JP 52719495 A JP52719495 A JP 52719495A JP 52719495 A JP52719495 A JP 52719495A JP 2944759 B2 JP2944759 B2 JP 2944759B2
Authority
JP
Japan
Prior art keywords
ciprofloxacin
composition
sulfonic acid
polystyrene sulfonic
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP52719495A
Other languages
English (en)
Japanese (ja)
Other versions
JPH09507679A (ja
Inventor
エイリ，ユサフ
ジャニ，ラジャニ
Original Assignee
アルコン ラボラトリーズ，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アルコン ラボラトリーズ，インコーポレイテッド filed Critical アルコン ラボラトリーズ，インコーポレイテッド
Publication of JPH09507679A publication Critical patent/JPH09507679A/ja
Application granted granted Critical
Publication of JP2944759B2 publication Critical patent/JP2944759B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP52719495A 1995-05-24 1995-05-24 抗菌性組成物 Expired - Fee Related JP2944759B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/006587 WO1996037191A1 (fr) 1995-05-24 1995-05-24 Compositions antibacteriennes

Publications (2)

Publication Number Publication Date
JPH09507679A JPH09507679A (ja) 1997-08-05
JP2944759B2 true JP2944759B2 (ja) 1999-09-06

Family

ID=22249170

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52719495A Expired - Fee Related JP2944759B2 (ja) 1995-05-24 1995-05-24 抗菌性組成物

Country Status (3)

Country Link
JP (1) JP2944759B2 (fr)
AU (1) AU705718B2 (fr)
WO (1) WO1996037191A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0201644A3 (en) * 1999-04-29 2004-05-28 Alza Corp Mountain View Liposome compositions for improved drug retention
WO2009124386A1 (fr) * 2008-04-07 2009-10-15 Interface Biologics Inc. Polythérapie pour le traitement des infections bactériennes
JP5624281B2 (ja) * 2009-04-21 2014-11-12 東亜薬品株式会社 光安定性に優れたキノロン系抗菌薬含有液体製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US5104649A (en) * 1988-05-11 1992-04-14 Monsanto Company Surface-functionalized biocidal polymers
CA2064160C (fr) * 1991-03-27 1998-08-11 Paul J. T. Missel Emploi de polysaccharides gelifiants combines a des substrats finement divises a action de vecteur des medicaments, dans des compositions ophthalmiques a usage local

Also Published As

Publication number Publication date
WO1996037191A1 (fr) 1996-11-28
JPH09507679A (ja) 1997-08-05
AU2762195A (en) 1996-12-11
AU705718B2 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
JP3450805B2 (ja) 水性医薬組成物
JP5705552B2 (ja) 眼痛を処置または防止するためのケトロラックトロメタミン組成物
US20010049366A1 (en) Topical solution formulations containing an antibiotic and a corticosteroid
US9114168B2 (en) Pharmaceutical compositions containing a fluoroquinolone antibiotic drug
KR20180017213A (ko) 포유류에서 내부 및 외부 귀의 감염에 대한 귀 치료용 조성물
EP0868909A2 (fr) Véhicule ophtalmique sous forme de solution
JP2003505511A (ja) 抗生物質およびｎｓａｉｄを含有する眼科用組成物
JP3153549B2 (ja) キノロンカルボン酸―金属イオン―酸錯体
EP0604570B1 (fr) Compositions contenant des antibiotiques quinolone et du sulfonate de polystyrol
JPH1160505A (ja) 防腐組成物
US5929115A (en) Anti-inflammatory eye drop
JP2007509952A (ja) ロテプレドノールエタボネートおよびトブラマイシンの局所眼科用懸濁液
JPS61143318A (ja) 新規な製剤およびその調整方法
JP2944759B2 (ja) 抗菌性組成物
JP2530491B2 (ja) ヒアルロン酸点眼液
EP2419081B1 (fr) Compositions ophtalmiques aqueuses contenant des agents thérapeutiques anioniques
KR100261585B1 (ko) 항염증점안제
JP2000247887A (ja) 水性懸濁液剤およびその製造方法
CA2191597A1 (fr) Compositions antibacteriennes
JPH0662442B2 (ja) 点鼻薬
JPH115750A (ja) 点眼剤
JP2002544164A (ja) ５−（２−クロロエチル）−４−メチルチアゾールエジシレート（クロメチアゾールエジシレート）の非経口処方物
WO2001035946A2 (fr) Administration intranasale de raloxifene et de tamoxifene
WO2007099431A2 (fr) Compositions pharmaceutiques liquides aqueuses de gatifloxacine

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees